NAM
JAZZ icon

Nissay Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Nissay Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-7,094
Closed -$854K – 766
2024
Q1 		$854K Buy
7,094
+101
+1% +$12.4K 0.01% 669
2023
Q4 		$860K Sell
6,993
-117
-2% -$14.6K 0.01% 648
2023
Q3 		$920K Buy
7,110
+288
+4% +$38.4K 0.01% 624
2023
Q2 		$846K Sell
6,822
-70
-1% -$9.42K 0.01% 645
2023
Q1 		$1.01M Sell
6,892
-254
-4% -$37.6K 0.01% 600
2022
Q4 		$1.14M Sell
7,146
-267
-4% -$39.1K 0.01% 566
2022
Q3 		$988K Buy
7,413
+343
+5% +$52.2K 0.01% 594
2022
Q2 		$1.1M Sell
7,070
-229
-3% -$35.3K 0.01% 571
2022
Q1 		$1.14M Buy
7,299
+170
+2% +$24.7K 0.01% 586
2021
Q4 		$908K Buy
7,129
+540
+8% +$71K 0.01% 658
2021
Q3 		$858K Buy
6,589
+245
+4% +$37K 0.01% 652
2021
Q2 		$1.13M Buy
6,344
+154
+2% +$26.7K 0.01% 608
2021
Q1 		$1.02M Sell
6,190
-84
-1% -$13.8K 0.01% 603
2020
Q4 		$1.04M Sell
6,274
-163
-3% -$24.3K 0.02% 579
2020
Q3 		$918K Buy
6,437
+111
+2% +$13.8K 0.02% 557
2020
Q2 		$698K Buy
6,326
+592
+10% +$65.5K 0.01% 609
2020
Q1 		$572K Buy
5,734
+121
+2% +$15.6K 0.01% 557
2019
Q4 		$838K Buy
+5,613
New +$764K 0.02% 569
2019
Q3 		– Hold
0
– – – 585
2019
Q2 		– Hold
0
– – – 567
2019
Q1 		– Hold
0
– – – 548
2018
Q4 		– Hold
0
– – – 544
2018
Q3 		– Hold
0
– – – 526
2018
Q2 		– Sell
-4,860
Closed -$794K – 505
2018
Q1 		$734K Buy
4,860
+101
+2% +$14.8K 0.02% 530
2017
Q4 		$641K Buy
+4,759
New +$660K 0.02% 581

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

Nissay Asset Management's JAZZ Position: Q2 2024 in Review

Nissay Asset Management sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2024, closing a stake of 7,094 shares — an estimated $854K sold.

Nissay Asset Management first reported a position in JAZZ in Q4 2017 and held it in 20 quarters. The position peaked at $1.14M in Q4 2022. 456 funds tracked by Wall St. Rank hold JAZZ as of Q2 2024.

  • Nissay Asset Management reported no remaining Jazz Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Nissay Asset Management sold 7,094 Jazz Pharmaceuticals shares in Q2 2024, an estimated $854K.
  • Nissay Asset Management first reported a position in Jazz Pharmaceuticals in Q4 2017 and held it in 20 quarters.
  • Nissay Asset Management's Jazz Pharmaceuticals position peaked at $1.14M in Q4 2022.
  • 456 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2024.

Based on Nissay Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.